PATENT CLAIM ANALYSIS

Application Number: 15890436
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["544", "236000"]

Abstract:
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Claim (Index 14):
A method for inhibiting Rho kinase activity, comprising (a) providing target cells and a composition comprising a compound described in  claim 1 ; and (b) exposing said target cells to said composition under conditions such that said composition binds to said target cells so as to inhibit Rho kinase activity within said target cells.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.30909
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14759495', '14157564', '14797414', '16067619', '15503419']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8127472288668693
- 35 USC 102 Novelty (BERT): 0.6323822061538917
- Combined Prediction Score: 0.7947107265955716
- Mean Citation Score: 541.344386
- Max Citation Score: 598.7151
- Similarity Product: 556.8459793547273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test